Li Weng
- Topics
- MicroRNA in disease regulation (3 papers)Cancer-related molecular mechanisms research (3 papers)Genomics and Phylogenetic Studies (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Li Weng
12 papers receiving 650 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 564
- Oncology 132
- Cancer Research 99
- Genetics 96
- Cell Biology 80
Countries citing papers authored by Li Weng
This map shows the geographic impact of Li Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Weng more than expected).
Fields of papers citing papers by Li Weng
This network shows the impact of papers produced by Li Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Weng. The network helps show where Li Weng may publish in the future.
Co-authorship network of co-authors of Li Weng
This figure shows the co-authorship network connecting the top 25 collaborators of Li Weng. A scholar is included among the top collaborators of Li Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Weng. Li Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 11 | |
| 4 | 6 | |
| 5 | 13 | |
| 6 | 24 | |
| 7 | 36 | |
| 8 | MiR-4262 promotes cell apoptosis and inhibits proliferation of colon cancer cells: involvement of GALNT4. | 23 |
| 9 | 63 | |
| 10 | 14 | |
| 11 | 25 | |
| 12 | 39 | |
| 13 | 363 | |
| 14 | 47 |
About Li Weng
Li Weng is a scholar working on Cancer Research, Molecular Biology and Speech and Hearing, having authored 14 papers that have together received 664 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Molecular Biology (564 citations), Cancer Research (99 citations) and Cell Biology (80 citations). Li Weng has collaborated with scholars based in China and United States. Frequent co-authors include Shijie Xin, Wei Du, Molly Duman‐Scheel, Jinhua Xu, Jun Li, Changquan Ling, Xiang Lv, Binbin Cheng, Juan Du and Mingyi Shang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.